Cargando…

Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis

Introduction: Infection by SARS-CoV-2 and subsequent COVID-19 can cause viral sepsis. We investigated plasma protease activity patterns in COVID-19-induced sepsis with bacterial superinfection, as well as plasma proteomics and peptidomics in order to assess the possible implications of enhanced prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Dos Santos, Fernando, Li, Joyce B., Juocys, Nathalia, Mazor, Rafi, Beretta, Laura, Coufal, Nicole G., Lam, Michael T. Y., Odish, Mazen F., Irigoyen, Maria Claudia, O’Donoghue, Anthony J., Aletti, Federico, Kistler, Erik B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874325/
https://www.ncbi.nlm.nih.gov/pubmed/36710882
http://dx.doi.org/10.3389/fmolb.2022.1051471
_version_ 1784877785799458816
author Dos Santos, Fernando
Li, Joyce B.
Juocys, Nathalia
Mazor, Rafi
Beretta, Laura
Coufal, Nicole G.
Lam, Michael T. Y.
Odish, Mazen F.
Irigoyen, Maria Claudia
O’Donoghue, Anthony J.
Aletti, Federico
Kistler, Erik B.
author_facet Dos Santos, Fernando
Li, Joyce B.
Juocys, Nathalia
Mazor, Rafi
Beretta, Laura
Coufal, Nicole G.
Lam, Michael T. Y.
Odish, Mazen F.
Irigoyen, Maria Claudia
O’Donoghue, Anthony J.
Aletti, Federico
Kistler, Erik B.
author_sort Dos Santos, Fernando
collection PubMed
description Introduction: Infection by SARS-CoV-2 and subsequent COVID-19 can cause viral sepsis. We investigated plasma protease activity patterns in COVID-19-induced sepsis with bacterial superinfection, as well as plasma proteomics and peptidomics in order to assess the possible implications of enhanced proteolysis on major protein systems (e.g., coagulation). Methods: Patients (=4) admitted to the intensive care units (ICUs) at the University of California, San Diego (UCSD) Medical Center with confirmed positive test for COVID-19 by real-time reverse transcription polymerase chain reaction (RT-PCR) were enrolled in a study approved by the UCSD Institutional Review Board (IRB# 190699, Protocol #20-0006). Informed consent was obtained for the collection of blood samples and de-identified use of the data. Blood samples were collected at multiple time points and analyzed to quantify a) the circulating proteome and peptidome by mass spectrometry; b) the aminopeptidase activity in plasma; and c) the endopeptidase activity in plasma using fluorogenic substrates that are cleaved by trypsin-like endopeptidases, specific clotting factors and plasmin. The one patient who died was diagnosed with bacterial superinfection on day 7 after beginning of the study. Results: Spikes in protease activity (factor VII, trypsin-like activity), and corresponding increases in the intensity of peptides derived by hydrolysis of plasma proteins, especially of fibrinogen degradation products and downregulation of endogenous protease inhibitors were detected on day 7 for the patient who died. The activity of the analyzed proteases was stable in survivors. Discussion: The combination of multiomics and enzymatic activity quantification enabled to i) hypothesize that elevated proteolysis occurs in COVID-19-induced septic shock with bacterial superinfection, and ii) provide additional insight into malfunctioning protease-mediated systems, such as hemostasis.
format Online
Article
Text
id pubmed-9874325
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98743252023-01-26 Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis Dos Santos, Fernando Li, Joyce B. Juocys, Nathalia Mazor, Rafi Beretta, Laura Coufal, Nicole G. Lam, Michael T. Y. Odish, Mazen F. Irigoyen, Maria Claudia O’Donoghue, Anthony J. Aletti, Federico Kistler, Erik B. Front Mol Biosci Molecular Biosciences Introduction: Infection by SARS-CoV-2 and subsequent COVID-19 can cause viral sepsis. We investigated plasma protease activity patterns in COVID-19-induced sepsis with bacterial superinfection, as well as plasma proteomics and peptidomics in order to assess the possible implications of enhanced proteolysis on major protein systems (e.g., coagulation). Methods: Patients (=4) admitted to the intensive care units (ICUs) at the University of California, San Diego (UCSD) Medical Center with confirmed positive test for COVID-19 by real-time reverse transcription polymerase chain reaction (RT-PCR) were enrolled in a study approved by the UCSD Institutional Review Board (IRB# 190699, Protocol #20-0006). Informed consent was obtained for the collection of blood samples and de-identified use of the data. Blood samples were collected at multiple time points and analyzed to quantify a) the circulating proteome and peptidome by mass spectrometry; b) the aminopeptidase activity in plasma; and c) the endopeptidase activity in plasma using fluorogenic substrates that are cleaved by trypsin-like endopeptidases, specific clotting factors and plasmin. The one patient who died was diagnosed with bacterial superinfection on day 7 after beginning of the study. Results: Spikes in protease activity (factor VII, trypsin-like activity), and corresponding increases in the intensity of peptides derived by hydrolysis of plasma proteins, especially of fibrinogen degradation products and downregulation of endogenous protease inhibitors were detected on day 7 for the patient who died. The activity of the analyzed proteases was stable in survivors. Discussion: The combination of multiomics and enzymatic activity quantification enabled to i) hypothesize that elevated proteolysis occurs in COVID-19-induced septic shock with bacterial superinfection, and ii) provide additional insight into malfunctioning protease-mediated systems, such as hemostasis. Frontiers Media S.A. 2023-01-11 /pmc/articles/PMC9874325/ /pubmed/36710882 http://dx.doi.org/10.3389/fmolb.2022.1051471 Text en Copyright © 2023 Dos Santos, Li, Juocys, Mazor, Beretta, Coufal, Lam, Odish, Irigoyen, O’Donoghue, Aletti and Kistler. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Dos Santos, Fernando
Li, Joyce B.
Juocys, Nathalia
Mazor, Rafi
Beretta, Laura
Coufal, Nicole G.
Lam, Michael T. Y.
Odish, Mazen F.
Irigoyen, Maria Claudia
O’Donoghue, Anthony J.
Aletti, Federico
Kistler, Erik B.
Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title_full Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title_fullStr Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title_full_unstemmed Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title_short Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
title_sort plasma enzymatic activity, proteomics and peptidomics in covid-19-induced sepsis: a novel approach for the analysis of hemostasis
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874325/
https://www.ncbi.nlm.nih.gov/pubmed/36710882
http://dx.doi.org/10.3389/fmolb.2022.1051471
work_keys_str_mv AT dossantosfernando plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT lijoyceb plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT juocysnathalia plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT mazorrafi plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT berettalaura plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT coufalnicoleg plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT lammichaelty plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT odishmazenf plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT irigoyenmariaclaudia plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT odonoghueanthonyj plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT alettifederico plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis
AT kistlererikb plasmaenzymaticactivityproteomicsandpeptidomicsincovid19inducedsepsisanovelapproachfortheanalysisofhemostasis